JOHNSON & JOHNSON Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$386.1B
Holdings
20
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PTGXProtagonist Therapeutics Inc. | 2,449,183 | $94.5B | 24.48% | |
| 2 | CVRXCVRx, Inc. | 4,103,430 | $52.0B | 13.46% | |
| 3 | RAPPRapport Therapeutics, Inc. | 2,498,051 | $44.3B | 11.48% | |
| 4 | MGTXMeiraGTx Holdings plc | 6,641,064 | $40.4B | 10.47% | |
| 5 | CTNMContineum Therapeutics Inc. | 1,979,173 | $29.0B | 7.51% | |
| 6 | PRCTProcept BioRobotics Corporation | 357,939 | $28.8B | 7.46% | |
| 7 | LEGNLegend Biotech Corporation | 814,586 | $26.5B | 6.86% | |
| 8 | NMRANeumora Therapeutics, Inc. | 1,849,445 | $19.6B | 5.08% | |
| 9 | XNCRXencor, Inc. | 748,062 | $17.2B | 4.45% | |
| 10 | NBTXNanobiotix S.A. | 5,623,816 | $16.1B | 4.18% | |
| 11 | FATEFate Therapeutics, Inc. | 3,379,064 | $5.6B | 1.44% | |
| 12 | ARWRArrowhead Pharmaceuticals, Inc. | 247,598 | $4.7B | 1.21% | |
| 13 | RLYBRallybio Corporation | 3,636,363 | $3.5B | 0.90% | |
| 14 | VORVor Biopharma, Inc. | 1,074,658 | $1.2B | 0.31% | |
| 15 | NNOXNano-X Imaging Ltd. | 158,852 | $1.1B | 0.30% | |
| 16 | FLBStandard BioTools Inc | 311,967 | $545.9M | 0.14% | |
| 17 | LYELLyell Immunopharma Inc. | 823,317 | $526.9M | 0.14% | |
| 18 | TORCEURAdicet Bio, Inc. | 364,472 | $350.6M | 0.09% | |
| 19 | PHGEBiomX Inc. | 96,866 | $70.7M | 0.02% | |
| 20 | SENS1GBPSenseonics Holdings, Inc. | 54,621 | $28.6M | 0.01% |